HUP0303790A2 - Citalopram hidrogén-bromid-tartalmú tabletta - Google Patents

Citalopram hidrogén-bromid-tartalmú tabletta

Info

Publication number
HUP0303790A2
HUP0303790A2 HU0303790A HUP0303790A HUP0303790A2 HU P0303790 A2 HUP0303790 A2 HU P0303790A2 HU 0303790 A HU0303790 A HU 0303790A HU P0303790 A HUP0303790 A HU P0303790A HU P0303790 A2 HUP0303790 A2 HU P0303790A2
Authority
HU
Hungary
Prior art keywords
tablet containing
hydrogen bromide
containing citalopram
tablet
film
Prior art date
Application number
HU0303790A
Other languages
English (en)
Inventor
Pál Fekete
Szilvia Feikus
Széll Zsuzsa Szlávyné
Original Assignee
EGIS Gyógyszergyár Rt.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by EGIS Gyógyszergyár Rt. filed Critical EGIS Gyógyszergyár Rt.
Priority to HU0303790A priority Critical patent/HU227491B1/hu
Publication of HU0303790D0 publication Critical patent/HU0303790D0/hu
Priority to EP04798748A priority patent/EP1694321A1/en
Priority to PCT/HU2004/000110 priority patent/WO2005051374A1/en
Priority to EA200600932A priority patent/EA010290B1/ru
Priority to UAA200607053A priority patent/UA83094C2/ru
Priority to SK5053-2006A priority patent/SK50532006A3/sk
Priority to CZ20060376A priority patent/CZ2006376A3/cs
Priority to PL379864A priority patent/PL379864A1/pl
Publication of HUP0303790A2 publication Critical patent/HUP0303790A2/hu
Publication of HUP0303790A3 publication Critical patent/HUP0303790A3/hu
Priority to BG109587A priority patent/BG109587A/bg
Publication of HU227491B1 publication Critical patent/HU227491B1/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

A találmány tárgya hatóanyagként 40 mm-nél kisebb közepesszemcseméretű citalopram hidrogén-bromidot tartalmazó tabletta,filmtabletta és direkt préseléses eljárás a tabletta, valamint afilmtabletta magjának előállítására.
HU0303790A 2003-11-25 2003-11-25 Tablet containing citalopram hydrogen bromide HU227491B1 (en)

Priority Applications (9)

Application Number Priority Date Filing Date Title
HU0303790A HU227491B1 (en) 2003-11-25 2003-11-25 Tablet containing citalopram hydrogen bromide
PL379864A PL379864A1 (pl) 2003-11-25 2004-11-24 Tabletki bromowodorku citalopramu
UAA200607053A UA83094C2 (en) 2003-11-25 2004-11-24 Tablet of citalopram hydrobromide
PCT/HU2004/000110 WO2005051374A1 (en) 2003-11-25 2004-11-24 Tablets of citalopram hydrobromide
EA200600932A EA010290B1 (ru) 2003-11-25 2004-11-24 Таблетки циталопрама гидробромида
EP04798748A EP1694321A1 (en) 2003-11-25 2004-11-24 Tablets of citalopram hydrobromide
SK5053-2006A SK50532006A3 (sk) 2003-11-25 2004-11-24 Tablety hydrobromidu citalopramu
CZ20060376A CZ2006376A3 (cs) 2003-11-25 2004-11-24 Tablety hydrobromidu citalopramu
BG109587A BG109587A (bg) 2003-11-25 2006-06-23 Таблетки с циталопрам хидробромид

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU0303790A HU227491B1 (en) 2003-11-25 2003-11-25 Tablet containing citalopram hydrogen bromide

Publications (4)

Publication Number Publication Date
HU0303790D0 HU0303790D0 (en) 2004-03-01
HUP0303790A2 true HUP0303790A2 (hu) 2005-08-29
HUP0303790A3 HUP0303790A3 (en) 2005-09-28
HU227491B1 HU227491B1 (en) 2011-07-28

Family

ID=89981808

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0303790A HU227491B1 (en) 2003-11-25 2003-11-25 Tablet containing citalopram hydrogen bromide

Country Status (9)

Country Link
EP (1) EP1694321A1 (hu)
BG (1) BG109587A (hu)
CZ (1) CZ2006376A3 (hu)
EA (1) EA010290B1 (hu)
HU (1) HU227491B1 (hu)
PL (1) PL379864A1 (hu)
SK (1) SK50532006A3 (hu)
UA (1) UA83094C2 (hu)
WO (1) WO2005051374A1 (hu)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI358407B (en) * 2005-06-22 2012-02-21 Lundbeck & Co As H Crystalline base of escitalopram and orodispersibl

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6607751B1 (en) * 1997-10-10 2003-08-19 Intellipharamaceutics Corp. Controlled release delivery device for pharmaceutical agents incorporating microbial polysaccharide gum
IS6021A (is) * 2000-08-10 2001-10-20 H. Lundbeck A/S Lyfjasamsetningar sem innihalda sítalópram
AU2001100195B4 (en) * 2001-01-05 2001-12-20 H Lundbeck As Pharmaceutical composition containing citalopram.

Also Published As

Publication number Publication date
EA200600932A1 (ru) 2006-10-27
CZ2006376A3 (cs) 2006-10-11
BG109587A (bg) 2006-12-29
HU0303790D0 (en) 2004-03-01
HU227491B1 (en) 2011-07-28
EA010290B1 (ru) 2008-08-29
SK50532006A3 (sk) 2006-09-07
PL379864A1 (pl) 2006-11-27
UA83094C2 (en) 2008-06-10
WO2005051374A1 (en) 2005-06-09
EP1694321A1 (en) 2006-08-30
HUP0303790A3 (en) 2005-09-28

Similar Documents

Publication Publication Date Title
MXPA06007171A (es) Derivados de ciclohexano espirociclicos con afinidad para el receptor orl1.
TW200510375A (en) New compounds
MXPA03010201A (es) Derivados de 2-piridin-ciclohexan-1,4-diamina sustituidos.
GB2442893A (en) Method of dynamically assigning mobility configuration parameters for mobile entities
HUP0401020A2 (hu) Napraforgó-lecitint tartalmazó, sekély-sütésre alkalmas élelmiszer-kompozíció
NO20013444D0 (no) Triazolforbindelser med dopamin-D3-reseptor-affinet
IS8230A (is) Setið 2-amínótetralín til notkunar við meðferð á þunglyndi
NO20091976L (no) Nye forbindelser
DK1578406T3 (da) Farmaceutisk sammensætning med modificeret frigivelse
MY115433A (en) Film coated tablet of paracetamol and domperidone.
MXPA04001628A (es) Tuberia medica elaborada de polibutadieno.
ATE418530T1 (de) Kompaktiertes menthol
BR0309298A (pt) Método para estabilizar comprimidos de cloreto de bupropion
HUP0303790A2 (hu) Citalopram hidrogén-bromid-tartalmú tabletta
BG104034A (en) Method for the preparation of pharmaceutical compounds of antidepressive effect and against the parkinson syndrome effect
GB2342352B (en) Pure cis-tramadol hydrochloride production
NO20056220L (no) Derimiciklane fumerat-tabletter
WO2001049651A3 (de) Aminomethyl-phenyl-cyclohexanonderivate
TW200630109A (en) Drug for external use and adhesive patch
MXPA04004526A (es) N-metil-homocisteinas, su uso y metodo para su produccion.
YU61503A (sh) Nova so benzoilgvanidina
SE0103294D0 (sv) Lactate producing lactococcus strain
AP2003002897A0 (en) Processes and intermediates for preparing benzyl epoxides
WO2004103908A3 (en) Controlled oxygen addition for metal material
WO2005034971A3 (en) Antiviral agent

Legal Events

Date Code Title Description
HC9A Change of name, address

Owner name: EGIS GYOGYSZERGYAR NYILVANOSAN MUEKOEDOE RESZV, HU

Free format text: FORMER OWNER(S): EGIS GYOGYSZERGYAR RT., HU